tiprankstipranks
Biodexa Pharmaceuticals (BDRX)
NASDAQ:BDRX
Holding BDRX?
Track your performance easily

Biodexa Pharmaceuticals (BDRX) Cash flow

419 Followers

Biodexa Pharmaceuticals Cash Flow

BDRX's free cash flow for Q2 2022 was £―. For the 2022 fiscal year, BDRX's free cash flow was decreased by £3.29M and operating cash flow was £―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
-£ -6.01M£ -9.30M£ -6.49M£ -13.45M£ -12.95M
Investing Cash Flow
-£ -278.00K£ 2.57M£ -3.81M£ 9.04M£ -1.47M
Financing Cash Flow
-£ 8.80M£ 3.08M£ 18.73M£ -6.47M£ 10.28M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-£ 10.06M£ 7.55M£ 10.93M£ 2.34M£ 13.20M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-£ 9.04M£ 9.74M£ 14.11M-£ 10.96M
Issuance Of Debt
-£ -103.00K£ -6.62M£ 3.41M£ -5.88M£ -577.00K
Repayment Of Debt
-£ -103.00K£ -6.67M£ 3.41M£ -5.88M£ -577.00K
Free Cash Flow
-£ -6.01M£ -9.30M£ -6.49M£ -13.45M£ -12.95M
Domestic Sales
------
Foreign Sales
------
Currency in GBP

Biodexa Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis